Dr. Sadjad Fakouri Baygi is the Founder and Chief Executive Officer of Linker Sciences. He has over a decade of experience in computational and experimental mass spectrometry with a focus on applying high-resolution instrumentation to drug discovery and molecular characterization. His work spans method development, large-scale data analysis, cheminformatics, and precision workflows for identifying unknown compounds in complex matrices.

Sadjad has led industry projects integrating experimental design with AI/ML workflows to build scalable mass spectrometry platforms and end-to-end analytical pipelines for compound discovery and characterization. At Linker Sciences, he applies this expertise to develop a mass spectrometry-powered platform aimed at transforming drug discovery and development.